Neoadjuvant chemoradiotherapy with S-1 in patients with borderline resectable pancreatic cancer

被引：0
|
作者：
Hattori, Masashi
Fujii, Tsutomu
Suenaga, Masaya
Yamada, Suguru
Kanda, Mitsuro
Iwata, Naoki
Kobayashi, Daisuke
Tanaka, Chie
Nakayama, Goro
Sugimoto, Hiroyuki
Koike, Masahiko
Nomoto, Shuji
Fujiwara, Michitaka
Kodera, Yasuhiro
机构：
[1] Nagoya Univ, Dept Gastroenterol Surg Surg 2, Grad Sch Med, Nagoya, Aichi 4648601, Japan
[2] Nagoya Univ, Dept Surg Gastroenterol, Grad Sch Med, Nagoya, Aichi 4648601, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 03期
关键词：
D O I：
10.1200/jco.2014.32.3_suppl.302
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
302
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The role of neoadjuvant chemoradiotherapy in resectable pancreatic cancer
    Kim, H. J.
    Bang, S.
    Park, S. W.
    Chung, J. B.
    Song, S. Y.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A138 - A138
  • [32] Survival impact of neoadjuvant gemcitabine plus S-1 chemotherapy for patients with borderline resectable pancreatic carcinoma with arterial contact
    Murakami, Yoshiaki
    Uemura, Kenichiro
    Sudo, Takeshi
    Hashimoto, Yasushi
    Kondo, Naru
    Nakagawa, Naoya
    Takahashi, Shinya
    Sueda, Taijiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (01) : 37 - 47
  • [33] Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer
    Barreto, Savio George
    Shrikhande, Shailesh, V
    Sirohi, Bhawna
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2024, 15 (SUPPL 2) : 249 - 254
  • [34] Survival impact of neoadjuvant gemcitabine plus S-1 chemotherapy for patients with borderline resectable pancreatic carcinoma with arterial contact
    Yoshiaki Murakami
    Kenichiro Uemura
    Takeshi Sudo
    Yasushi Hashimoto
    Naru Kondo
    Naoya Nakagawa
    Shinya Takahashi
    Taijiro Sueda
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 37 - 47
  • [35] Neoadjuvant chemoradiation with IMRT in resectable and borderline resectable pancreatic cancer
    Kharofa, Jordan
    Tsai, Susan
    Kelly, Tracy
    Wood, Clint
    George, Ben
    Ritch, Paul
    Wiebe, Lauren
    Christians, Kathleen
    Evans, Douglas B.
    Erickson, Beth
    RADIOTHERAPY AND ONCOLOGY, 2014, 113 (01) : 41 - 46
  • [36] Strategy of Neoadjuvant Therapy for Resectable/Borderline Resectable Pancreatic Cancer
    Hashimoto, D.
    Satoi, S.
    Yamamoto, T.
    Yamaki, S.
    Hirooka, S.
    Ishida, M.
    Ikeura, T.
    Sekimoto, M.
    PANCREAS, 2021, 50 (07) : 1064 - 1064
  • [37] Neoadjuvant therapy in borderline resectable and resectable pancreatic cancer.
    Dhamija, Kriti
    Awuah, Kojo-Frimpong B.
    Marwaha, Alexander
    Kharoud, Harmeet
    Monga, Dulabh K.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 735 - 735
  • [38] Randomized phase II trial of chemoradiotherapy with S-1 versus combination chemotherapy with gemcitabine and S-1 as neoadjuvant treatment for resectable pancreatic cancer (JASPAC 04)
    Toyama, Hirochika
    Sugiura, Teiichi
    Fukutomi, Akira
    Asakura, Hirofumi
    Takeda, Yuriko
    Yamamoto, Kouji
    Hirano, Satoshi
    Satoi, Sohei
    Matsumoto, Ippei
    Takahashi, Shinichiro
    Morinaga, Soichiro
    Yoshida, Makoto
    Sakuma, Yasunaru
    Iwamoto, Hidetaka
    Shimizu, Yasuhiro
    Uesaka, Katsuhiko
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [39] Editorial: Neoadjuvant treatment for resectable and borderline resectable pancreatic cancer
    Massani, Marco
    Stecca, Tommaso
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [40] Neoadjuvant treatment of primarily resectable and borderline resectable pancreatic cancer
    Scheufele, F.
    Friess, H.
    CHIRURG, 2020, 91 (05): : 391 - 395
12345